Geode Capital Management LLC Grows Stake in Teleflex Incorporated $TFX

Geode Capital Management LLC boosted its stake in Teleflex Incorporated (NYSE:TFX) by 10.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 985,684 shares of the medical technology company’s stock after buying an additional 94,679 shares during the quarter. Geode Capital Management LLC owned approximately 2.23% of Teleflex worth $120,312,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of TFX. AQR Capital Management LLC increased its stake in Teleflex by 478.1% during the 3rd quarter. AQR Capital Management LLC now owns 2,366,131 shares of the medical technology company’s stock worth $287,603,000 after buying an additional 1,956,811 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in shares of Teleflex by 0.3% in the third quarter. Dimensional Fund Advisors LP now owns 1,245,614 shares of the medical technology company’s stock valued at $152,408,000 after acquiring an additional 3,812 shares in the last quarter. Abrams Bison Investments LLC purchased a new position in shares of Teleflex in the third quarter valued at approximately $112,317,000. Thrivent Financial for Lutherans boosted its stake in shares of Teleflex by 40.6% in the fourth quarter. Thrivent Financial for Lutherans now owns 774,034 shares of the medical technology company’s stock worth $94,463,000 after acquiring an additional 223,585 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership increased its position in shares of Teleflex by 123.9% during the third quarter. Arrowstreet Capital Limited Partnership now owns 660,800 shares of the medical technology company’s stock worth $80,855,000 after purchasing an additional 365,663 shares in the last quarter. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Teleflex Stock Down 1.7%

Shares of NYSE TFX opened at $129.90 on Friday. The company has a market capitalization of $5.75 billion, a P/E ratio of -5.70, a P/E/G ratio of 0.98 and a beta of 0.82. The company has a debt-to-equity ratio of 0.82, a current ratio of 2.55 and a quick ratio of 2.03. The company has a 50 day simple moving average of $127.08 and a 200-day simple moving average of $118.04. Teleflex Incorporated has a 1 year low of $100.18 and a 1 year high of $139.67.

Teleflex (NYSE:TFX) last issued its quarterly earnings data on Thursday, May 7th. The medical technology company reported $1.39 earnings per share for the quarter, topping the consensus estimate of $1.21 by $0.18. The company had revenue of $548.30 million during the quarter, compared to analyst estimates of $536.91 million. Teleflex had a positive return on equity of 13.29% and a negative net margin of 35.88%.The firm’s revenue for the quarter was up 32.3% compared to the same quarter last year. During the same period in the prior year, the business posted $1.44 earnings per share. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. On average, equities research analysts predict that Teleflex Incorporated will post 6.7 earnings per share for the current year.

Teleflex Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Monday, May 25th will be issued a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 1.0%. The ex-dividend date is Friday, May 22nd. Teleflex’s dividend payout ratio is currently -5.96%.

Wall Street Analyst Weigh In

Several research analysts recently commented on TFX shares. Royal Bank Of Canada raised Teleflex from a “sector perform” rating to an “outperform” rating and increased their price objective for the company from $135.00 to $155.00 in a research note on Friday, May 8th. Bank of America raised shares of Teleflex from an “underperform” rating to a “neutral” rating and set a $135.00 target price for the company in a report on Monday, April 13th. Mizuho set a $140.00 target price on shares of Teleflex in a research report on Friday, May 8th. Weiss Ratings reissued a “sell (d)” rating on shares of Teleflex in a research note on Friday, March 27th. Finally, Needham & Company LLC boosted their price target on shares of Teleflex from $138.00 to $147.00 and gave the stock a “buy” rating in a research report on Thursday, February 26th. Three investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Teleflex has a consensus rating of “Hold” and an average price target of $144.00.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.